ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Nanobiotix SA

Nanobiotix SA (NBTX)

3.155
0.065
( 2.10% )
업데이트: 02:46:21

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

가격
3.155
매수가
3.03
매도가
3.28
거래량
9,757
3.0475 일간 변동폭 3.38
0.00 52주 범위 0.00
market_cap
전일 종가
3.09
개장가
3.38
최근 거래 시간
39
@
3.26
마지막 거래 시간
02:31:52
재정 규모
US$ 31,057
VWAP
3.1831
평균 볼륨(3m)
-
발행 주식
47,133,328
배당수익률
-
주가수익률
-3.55
주당순이익(EPS)
-0.84
매출
36.21M
순이익
-39.7M

Nanobiotix SA 정보

Nanobiotix SA is a clinical-stage biotechnology company that focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying ... Nanobiotix SA is a clinical-stage biotechnology company that focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its lead product candidate is NBTXR3, a preclinical research program for cancer immunotherapies. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Paris, Paris, Fra
설립됨
-
Nanobiotix SA is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker NBTX. The last closing price for Nanobiotix was US$3.09. Over the last year, Nanobiotix shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Nanobiotix currently has 47,133,328 shares in issue. The market capitalisation of Nanobiotix is US$145.64 million. Nanobiotix has a price to earnings ratio (PE ratio) of -3.55.

NBTX 최신 뉴스

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

NBTX - Frequently Asked Questions (FAQ)

What is the current Nanobiotix share price?
The current share price of Nanobiotix is US$ 3.155
How many Nanobiotix shares are in issue?
Nanobiotix has 47,133,328 shares in issue
What is the market cap of Nanobiotix?
The market capitalisation of Nanobiotix is USD 145.64M
What is the 1 year trading range for Nanobiotix share price?
Nanobiotix has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Nanobiotix?
The price to earnings ratio of Nanobiotix is -3.55
What is the cash to sales ratio of Nanobiotix?
The cash to sales ratio of Nanobiotix is 3.89
What is the reporting currency for Nanobiotix?
Nanobiotix reports financial results in EUR
What is the latest annual turnover for Nanobiotix?
The latest annual turnover of Nanobiotix is EUR 36.21M
What is the latest annual profit for Nanobiotix?
The latest annual profit of Nanobiotix is EUR -39.7M
What is the registered address of Nanobiotix?
The registered address for Nanobiotix is 60 RUE DE WATTIGNIES, PARIS, PARIS, 75012
What is the Nanobiotix website address?
The website address for Nanobiotix is www.nanobiotix.com
Which industry sector does Nanobiotix operate in?
Nanobiotix operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
RAYRaytech Holding Ltd
US$ 2.155
(147.70%)
84M
TSVT2seventy bio Inc
US$ 4.945
(76.61%)
29.22M
SYRSSyros Pharmaceuticals Inc
US$ 0.1549
(69.10%)
646.37M
HSAIHesai Group
US$ 22.45
(40.22%)
21.57M
TNONTenon Medical Inc
US$ 1.7501
(40.01%)
30.3M
WCTWellchange Holdings Company Limited
US$ 0.6265
(-75.04%)
25.75M
ARVNArvinas Inc
US$ 8.44
(-51.94%)
12.35M
LZMHLZ Technology Holdings Ltd
US$ 9.60
(-38.70%)
472.88k
SPGCSacks Parente Golf Inc
US$ 0.1089
(-31.98%)
28.59M
ARBBARB IOT Group Ltd
US$ 0.718748
(-28.13%)
2M
SYRSSyros Pharmaceuticals Inc
US$ 0.1549
(69.10%)
639.51M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0402
(20.00%)
379.61M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7.66
(3.79%)
234.68M
NVDANVIDIA Corporation
US$ 108.52
(1.44%)
224.5M
CUTRCutera Inc
US$ 0.1145
(-10.89%)
207.15M

NBTX Discussion

게시물 보기
glenn1919 glenn1919 3 월 전
NBTX.......................https://stockcharts.com/h-sc/ui?s=NBTX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 월 전
NBTX...........................https://stockcharts.com/h-sc/ui?s=NBTX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 11 월 전
NBTX 10Q due 4/3
👍️0
Monksdream Monksdream 11 월 전
NBTX under $10
👍️0
Monksdream Monksdream 2 년 전
Nanobiotix SA NASDAQ: NBTX

GoSymbol lookup
Health Care : Biotechnology | Small Cap Value | Based in FranceCompany profile
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
This security is an American depositary receipt
ADR Fees
👍️0
Monksdream Monksdream 2 년 전
July 10, 2023
4:21 am ET
*Nanobiotix shares are trading higher after the company entered into a license agreement with Janssen Pharmaceutical for global co-development and commercialization of NBTXR3.
Benzinga
2:19 am ET
*Nanobiotix Enters License Agreement With Janssen Pharmaceutical For Worldwide Co-Development And Commercialization Of Potential First-In-Class Radioenhancer NBTXR3
Benzinga
Nanobiotix SA NASDAQ: NBTX

GoSymbol lookup
Health Care : Biotechnology | Small Cap Value | Based in FranceCompany profile
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
This security is an American depositary receipt
ADR Fees
👍️0

최근 히스토리

Delayed Upgrade Clock